American Journal of Cardiology

Article	Citations
Meta-analysis of Effect of Statins in Patients with COVID-19	135
Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients	134
Right Ventricular–Pulmonary Arterial Coupling in Secondary Tricuspid Regurgitation	68
Meta-Analysis of Inclisiran for the Treatment of Hypercholesterolemia	67
COVID-19 Vaccine and Myocarditis	66
Usefulness of Elevated Troponin to Predict Death in Patients With COVID-19 and Myocardial Injury	58
Meta-Analysis of the Effect of Aspirin on Mortality in COVID-19	53
Validation of an Integrated Risk Tool, Including Polygenic Risk Score, for Atherosclerotic Cardiovascular Disease in Multiple Ethnicities and Ancestries	50
Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease	44
Meta-Analysis of Gender Disparities in In-hospital Care and Outcomes in Patients with ST-Segment Elevation Myocardial Infarction	43
Effect of a Multidisciplinary Pulmonary Embolism Response Team on Patient Mortality	39
Arrhythmogenic Right Ventricular Cardiomyopathy Presenting as Clinical Myocarditis in Women	39
Lipid Profile and Subsequent Cardiovascular Disease among Young Adults Aged < 50 Years	37
Meta-Analysis of Atrial Fibrillation in Patients With COVID-19	37
Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination	36
Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension S	35
Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes	35
Catheter Ablation for Atrial Fibrillation in Patients With Concurrent Heart Failure	33
Contemporary National Trends and Outcomes of Pulmonary Embolism in the United States	33
Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel	33
Meta-analysis of the Usefulness of Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction	33
Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification	32
Prognostic Value of Elevated Cardiac Troponin I in Hospitalized Covid-19 Patients	32
Meta-Analysis of Bioprosthetic Valve Thrombosis After Transcatheter Aortic Valve Implantation	32
Meta-analysis of Cardiovascular Events and Related Biomarkers Comparing Survivors Versus Non-survivors in Patients With COVID-19	31

Inappropriate Dosing of Direct Oral Anticoagulants in Patients with Atrial Fibrillation	31
Very High High-Density Lipoprotein Cholesterol Levels and Cardiovascular Mortality	31
Trends in Acute Myocarditis Related Pediatric Hospitalizations in the United States, 2007–2016	30
Comparison of the Efficacy and Safety of Sacubitril/Valsartan versus Ramipril in Patients With ST-Segment Elevation Myocardial Infarction	29
Exercise Preconditioning as a Cardioprotective Phenotype	29
Racial and Socioeconomic Disparities in Cardiotoxicity Among Women With HER2-Positive Breast Cancer	29
Meta-Analysis of Point-of-Care Lung Ultrasonography Versus Chest Radiography in Adults With Symptoms of Acute Decompensated Heart Failure	27
Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry)	27
Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis	27
Functional Tricuspid Regurgitation and Right Atrial Remodeling in Heart Failure With Preserved Ejection Fraction	27
Assessment of the Modified CHA2DS2VASc Risk Score in Predicting Mortality in Patients Hospitalized With COVID-19	26
Gaps and Disparities in Primary Prevention Statin Prescription During Outpatient Care	26
Coronary Artery Disease as the Cause of Sudden Cardiac Death Among Victims < 50 Years of Age	26
Meta-Analysis Comparing Catheter-Directed Thrombolysis Versus Systemic Anticoagulation Alone for Submassive Pulmonary Embolism	26
Redo-Transcatheter Aortic Valve Implantation Using the SAPIEN 3/Ultra Transcatheter Heart Valves—Expert Consensus on Procedural Planning and Techniques	26
Closing Gaps in Lifestyle Adherence for Secondary Prevention of Coronary Heart Disease	25
Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)	25
Risk of Cardiovascular Events After COVID-19	25
Overview of Aspirin and Platelet Biology	25
Normative Reference Values of Cardiac Output by Pulsed-Wave Doppler Echocardiography in Adults	25
Right Ventricular Myocardial Work Characterization in Patients With Pulmonary Hypertension and Relation to Invasive Hemodynamic Parameters and Outcomes	25
Meta-analysis Comparing Outcomes in Patients With and Without Cardiac Injury and Coronavirus Disease 2019 (COVID 19)	24
Pericardial Involvement in Cancer	24
Inflammatory Markers and Risk of Heart Failure With Reduced to Preserved Ejection Fraction	24
Incidence and Mortality Trends of Atrial Fibrillation/Atrial Flutter in the United States 1990 to 2017	23
Meta-Analysis of Valve-in-Valve Transcatheter Aortic Valve Implantation Versus Redo-surgical Aortic Valve Replacement in Failed Bioprosthetic Aortic Valve	23
Incidence of Myopericarditis and Myocardial Injury in Coronavirus Disease 2019 Vaccinated Subjects	22
Meta-analysis of the Effect of Colchicine on Mortality and Mechanical Ventilation in COVID-19	22
Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion	22
Coronary Artery Disease Without Standard Cardiovascular Risk Factors	22
Comparison of Characteristics and Outcomes of Patients With Acute Myocardial Infarction With Versus Without Coronarvirus-19	22
Influence of Body Weight and Diabetes Mellitus in Patients With Pulmonary Hypertension	21
Impact of Arrhythmias on Hospitalizations in Patients With Cardiac Amyloidosis	21
Aspirin for Primary Prevention of Cardiovascular Disease in the 21st Century: A Review of the Evidence	21
Impact of Sustained Weight Loss on Cardiometabolic Outcomes	21
Usefulness of the American Heart Association's Ideal Cardiovascular Health Measure to Predict Long-term Major Adverse Cardiovascular Events (From the Heart SCORE Study)	21
Meta-Analysis of Usefulness of Cerebral Embolic Protection During Transcatheter Aortic Valve Implantation	21
Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents E	21
Relation of Neighborhood Disadvantage to Heart Failure Symptoms and Hospitalizations	20
Sex-Specific Differences in Etiology and Prognosis in Patients With Significant Tricuspid Regurgitation	20
Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial Fibrillation	20
Long-Term Prognostic Value of the Society of Thoracic Surgery Risk Score in Patients Undergoing Transcatheter Aortic Valve Implantation (From the OCEAN-TAVI Registry)	20
Effect of In Utero Non-Steroidal Anti-Inflammatory Drug Therapy for Severe Ebstein Anomaly or Tricuspid Valve Dysplasia (NSAID Therapy for Fetal Ebstein anomaly)	20
Artificial Intelligence-Enabled Electrocardiography to Screen Patients with Dilated Cardiomyopathy	20
Prevalence and Long-term Outcomes of Patients with Coronary Artery Ectasia Presenting with Acute Myocardial Infarction	19
Association Between Periodontal Disease and Cardiovascular Disease (from the NHANES)	19
Prevalence of Acute Pulmonary Embolism at Autopsy in Patients With COVID-19	19
Prognostic Implications of Right Ventricular Systolic Dysfunction in Cardiac Amyloidosis	19
Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves	19
Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction	19

Meta-Analysis of Nonalcoholic Fatty Liver Disease and Incident Heart Failure	19
Associations Between Socioeconomic Context and Congenital Heart Disease Related Outcomes in Adolescents and Adults	19
Ventricular Fibrillation Storm in Coronavirus 2019	18
Impact and Determinants of High-Sensitivity Cardiac Troponin-T Concentration in Patients With COVID-19 Admitted to Critical Care	18
Relation of Bariatric Surgery to Inpatient Cardiovascular Outcomes (from the National Inpatient Sample)	18
What Causes Hypertrophic Cardiomyopathy?	18
Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT])	18
Trends in Outcomes of Transcatheter and Surgical Aortic Valve Replacement in the United States (2012–2017)	18
Usefulness of Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina Pectoris	18
Prognostic Implications of Significant Isolated Tricuspid Regurgitation in Patients With Atrial Fibrillation Without Left-Sided Heart Disease or Pulmonary Hypertension	18
Effect of Earlier Atrioventricular Valve Intervention on Survival After the Fontan Operation	18
Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy	18
Updated Meta-Analysis Assessing the Cardiovascular Efficacy of Tirzepatide	18
Admissions Rate and Timing of Revascularization in the United States in Patients With Non-ST-Elevation Myocardial Infarction	18
Relation of Atrial Fibrillation to Cognitive Decline (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study)	18
Analysis of Adverse Events Related to Impella Usage (from the Manufacturer and User Facility Device Experience and National Inpatient Sample Databases)	18
Mortality Risk Assessment Using CHA(2)DS(2)-VASc Scores in Patients Hospitalized With Coronavirus Disease 2019 Infection	17
Meta-Analysis of Randomized Clinical Trials Comparing the Impact of Implantable Loop Recorder Versus Usual Care After Ischemic Stroke for Detection of Atrial Fibrillation and Stroke Risk	17
Effectiveness of the 40-Minute Handmade Manikin Program to Teach Hands-on Cardiopulmonary Resuscitation at School Communities	17
Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis	17
Usefulness of Global Longitudinal Strain to Predict Heart Failure Progression in Patients With Nonobstructive Hypertrophic Cardiomyopathy	17
Demographic and Regional Trends of Mortality in Patients With Acute Myocardial Infarction in the United States, 1999 to 2019	17
C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations	17
Impact of Active and Historical Cancer on Short- and Long-Term Outcomes in Patients With Acute Myocardial Infarction	17
Frailty and Post-hospitalization Outcomes in Patients With Heart Failure With Preserved Ejection Fraction	17
Optimization of GRACE Risk Stratification by N-Terminal Pro-B-type Natriuretic Peptide Combined With D-Dimer in Patients With Non-ST-Elevation Myocardial Infarction	16
Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial)	16
Prognostically Distinct Phenotypes of Metabolic Health Beyond Obesity in Aortic Stenosis	16
COVID-19, POCUS, and Takotsubo	16
Relation of Aspartate Aminotransferase to Alanine Aminotransferase Ratio to Nutritional Status and Prognosis in Patients With Acute Heart Failure	16
Meta-Analysis Comparing Distal Radial Artery Approach Versus Traditional for Coronary Procedures	16
Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years	16
Comparison of Outcomes After Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction	16
COVID-19 and Gender Disparities in Pediatric Cardiologists with Dependent Care Responsibilities	16
Characteristics of COVID-19 Myocarditis With and Without Multisystem Inflammatory Syndrome	16
Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies)	16
Prognostic Value of Baseline Sarcopenia on 1-year Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation	16
Trends in Pulmonary Embolism Deaths Among Young Adults Aged 25 to 44 Years in the United States, 1999 to 2019	16
Relation of Poor Handgrip Strength or Slow Walking Pace to Risk of Myocardial Infarction and Fatality	15
Meta-Analysis Comparing Safety and Efficacy of Left Bundle Branch Area Pacing Versus His Bundle Pacing	15
Barriers and Facilitators of Palliative Care and Advance Care Planning in Adults With Congenital Heart Disease	15
Reasons for Screen Failure for Transcatheter Mitral Valve Repair and Replacement	15
Spontaneous Coronary Artery Dissection and Menopause	15
Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York	15
Prognostic Implications of Increased Right Ventricular Wall Tension in Secondary Tricuspid Regurgitation	15
Relation of First and Total Recurrent Atherosclerotic Cardiovascular Disease Events to Increased Lipoprotein(a) Levels Among Statin Treated Adults With Cardiovascular Disease	15
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study)	15
Impact of High Body Mass Index on Vascular and Bleeding Complications After Transcatheter Aortic Valve Implantation	15
The Trajectory of Lipoprotein(a) During the Peri- and Early Postinfarction Period and the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition	15
Procedural and Short-Term Outcomes of Percutaneous Left Atrial Appendage Closure in Patients With Cancer	15
Effects of Diet on 10-Year Atherosclerotic Cardiovascular Disease Risk (from the DASH Trial)	14
Meta-Analysis of Transradial vs Transfemoral Access for Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction	14
Comparison of Outcomes in Patients With Takotsubo Syndrome With-vs-Without Cardiogenic Shock	14
Continuous Thermodilution Method to Assess Coronary Flow Reserve	14
Meta-Analysis Comparing Outcomes With Bifurcation Percutaneous Coronary Intervention Techniques	14
Usefulness of Beta-Blockers to Control Symptoms in Patients With Pericarditis	14
Prognostic Impact of Branch Vessel Involvement on Computed Tomography versus Clinical Presentation of Malperfusion in Patients With Type a Acute Aortic Dissection	14
Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis	14
Long-Term Efficacy and Safety of ARRY-371797 (PF-07265803) in Patients With Lamin A/C–Related Dilated Cardiomyopathy	14
Prediction Model Using Machine Learning for Mortality in Patients with Heart Failure	14
Predictors of Recurrent Ischemic Events in Patients With ST-Segment Elevation Myocardial Infarction	14
Gender Disparities in Cardiogenic Shock Treatment and Outcomes	14
Meta-analysis Comparing Early Outcomes Following Transcatheter Aortic Valve Implantation With the Evolut Versus Sapien 3 Valves	14
The Effect of Anticoagulation Use on Mortality in COVID-19 Infection	14
Early Feasibility of Automated Artificial Intelligence Angiography Based Fractional Flow Reserve Estimation	14
Thoracic Aortic Calcium for the Prediction of Stroke Mortality (from the Coronary Artery Calcium Consortium)	14
Influence of Prolapse Volume in Mitral Valve Prolapse	13
Burden of Recurrent Pericarditis on Health-Related Quality of Life	13
Transcatheter Aortic Valve Implantation During the COVID-19 Pandemic	13
Trends and Predictors of Transcatheter Aortic Valve Implantation Related In-Hospital Mortality (From the National Inpatient Sample Database)	13
Meta-Analysis Comparing Valve Durability Among Different Transcatheter and Surgical Aortic Valve Bioprosthesis	13
Long-Term Outcomes Stratified by Body Mass Index in Patients Undergoing Transcatheter Aortic Valve Implantation	13
Meta-Analysis Comparing the Frequency of Carotid Artery Stenosis in Patients With Atrial Fibrillation and Vice Versa	13
Dose of Direct Oral Anticoagulants and Adverse Outcomes in Asia	13
Myopericarditis After COVID-19 Booster Dose Vaccination	13
Effect of Gender on Prognosis in Patients With Takotsubo Syndrome (from a Nationwide Perspective)	13
Lipoprotein(a) Testing Patterns in a Large Health System	13
Myocardial Work, an Echocardiographic Measure of Post Myocardial Infarct Scar on Contrast-Enhanced Cardiac Magnetic Resonance	13
Patient and Provider Perspectives on Remote Monitoring of Pacemakers and Implantable Cardioverter-Defibrillators	13
Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation	13

dST-Tiso Interval, a Novel Electrocardiographic Marker of Ventricular Arrhythmia Inducibility in Individuals With Ajmaline-Induced Brugada Type I Pattern	13
Impact of Frailty on Outcomes After Transcatheter Edge-to-Edge Repair With MitraClip (from the National Inpatient Sample Database)	13
Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine	13
At the Crossroads! Time to Start Taking Smartwatches Seriously	13
Meta-Analysis Comparing Venoarterial Extracorporeal Membrane Oxygenation With or Without Impella in Patients With Cardiogenic Shock	13
Meta-Analysis of Population Characteristics and Outcomes of Patients Undergoing Pericardiectomy for Constrictive Pericarditis	13
Aspirin in Primary Prevention: What Changed? A Critical Appraisal of Current Evidence	13
Gender, Age, and Regional Disparities in the Incidence and Mortality Trends of Infective Endocarditis in the United States Between 1990 and 2019	13
Comparison of the Usefulness of Strain Imaging by Echocardiography Versus Computed Tomography to Detect Right Ventricular Systolic Dysfunction in Patients With Significant Secondary Tricuspid Regurgit	13
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair	13
Supravalvular Aortic Stenosis and the Risk of Premature Death Among Patients With Homozygous Familial Hypercholesterolemia	13
Clinical and Hemodynamic Effects of Percutaneous Edge-to-Edge Mitral Valve Repair in Atrial Versus Ventricular Functional Mitral Regurgitation	13
Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation	12
Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure	12
Hemodynamic Profiles of Shock in Patients With COVID-19	12
Six-Month Outcomes for COVID-19 Negative Patients with Acute Myocardial Infarction Before Versus During the COVID-19 Pandemic	12
Comparison of Prevalence, Presentation, and Prognosis of Acute Coronary Syndromes in ≤35 years, 36 – 54 years, and ≥ 55 years Patients	12
Dual Antiplatelet Therapy De-escalation Strategies	12
Comparison of Long-Term Outcomes in Men versus Women Undergoing Percutaneous Coronary Intervention	12
Risk Markers for Limited Coronary Artery Calcium in Persons With Significant Aortic Valve Calcium (From the Multi-ethnic Study of Atherosclerosis)	12
Alcohol Consumption and Systemic Hypertension (from the Third National Health and Nutrition Examination Survey)	12
Cardiac Amyloidosis Screening at Trigger Finger Release Surgery	12
Trends in the Outcomes of High-risk Percutaneous Ventricular Assist Device-assisted Percutaneous Coronary Intervention, 2008-2018	12
Meta-analysis Evaluating the Use of Statins to attenuate Cardiotoxicity in Cancer Patients receiving Anthracyclines and Trastuzumab-based Chemotherapy	12
Cardiovascular Events and Mortality in Patients With Atrial Fibrillation and Anemia (from the Fushimi AF Registry)	12
Comprehensive Geriatric Assessment and Exercise Capacity in Cardiac Rehabilitation for Patients Referred to Transcatheter Aortic Valve Implantation	12
Heart Failure Incidence Following ST-Elevation Myocardial Infarction	12
Healthcare Expenditure Associated With Polypharmacy in Older Adults With Cardiovascular Diseases	12
Relation of Cannabis Use to Elevated Atherosclerotic Cardiovascular Disease Risk Score	12
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development	12
Association of Coronary Calcium, Carotid Wall Thickness, and Carotid Plaque Progression With Low-Density Lipoprotein and High-Density Lipoprotein Particle Concentration Measured by Ion Mobility (From	12
Meta-Analysis of Early Intervention Versus Conservative Management for Asymptomatic Severe Aortic Stenosis	12
Effect of Adenotonsillectomy on Cardiac Function in Children Age 5-13 Years With Obstructive Sleep Apnea	12
Changes in Global Left Ventricular Myocardial Work Indices and Stunning Detection 3 Months After ST-Segment Elevation Myocardial Infarction	12
Usefulness of Coronary Computed Tomographic Angiography to Evaluate Coronary Artery Disease in Radiotherapy-Treated Breast Cancer Survivors	12
Sex-Based Differences in Prevalence and Outcomes of Common Acute Conditions Associated With Type 2 Myocardial Infarction	12
Impact of Chronic Obstructive Pulmonary Disease in Heart Failure With Preserved Ejection Fraction	12
Blood Lead Levels and Risk of Deaths from Cardiovascular Disease	11
Impact of Digoxin Use on Interstage Outcomes of Single Ventricle Heart Disease (From a NPC-QIC Registry Analysis)	11
Standardized Measurement of Femoral Artery Depth by Computed Tomography to Predict Vascular Complications After Transcatheter Aortic Valve Implantation	11
Meta-Analysis Comparing Distal Radial Versus Traditional Radial Percutaneous Coronary Intervention or Angiography	11
Cardiac Stress Testing After Coronary Revascularization	11
Extramitral Valvular Cardiac Involvement in Patients With Significant Secondary Mitral Regurgitation	11
Comparison of Accuracy of Estimation of Cardiac Output by Thermodilution Versus the Fick Method Using Measured Oxygen Uptake	11
Relation of Cigarette Smoking and Heart Failure in Adults ≥65 Years of Age (From the Cardiovascular Health Study)	11
Overview of Current and Emerging Therapies for Amyloid Transthyretin Cardiomyopathy	11
COVID-19 and the Prehospital Incidence of Acute Cardiovascular Events (from the Nationwide US EMS)	11
Effect of the Emergency Department Assessment of Chest Pain Score on the Triage Performance in Patients With Chest Pain	11
Cardiovascular Care Innovation through Data-Driven Discoveries in the Electronic Health Record	11
Mitral Regurgitation Following Acute Myocardial Infarction Treated by Percutaneous Coronary Intervention—Prevalence, Risk factors, and Predictors of Outcome	11
Characteristics and Outcomes of Young Patients With ST-Elevation Myocardial Infarction Without Standard Modifiable Risk Factors	11
REDUCE-IT Eligibility and Preventable Cardiovascular Events in the US Population (from the National Health and Nutrition Examination Survey [NHANES])	11
Management Strategies for Atrial Fibrillation and Flutter in Patients with Transthyretin Cardiac Amyloidosis	11
A Meta-analysis of Intravenous Iron Therapy for Patients With Iron Deficiency and Heart Failure	11
Impact of Lipoprotein(a) as a Residual Risk Factor in Long-Term Cardiovascular Outcomes in Patients With Acute Coronary Syndrome Treated With Statins	11
Prognostic Value of Electrocardiographic QRS Diminution in Patients Hospitalized With COVID-19 or Influenza	11
Meta-Analysis Comparing Valve in Valve Transcatheter Mitral Valve Replacement Versus Redo Surgical Mitral Valve Replacement for Degenerating Bioprosthetic Valves	11
Impact of Cardiac Implantable Electronic Devices on Cost and Length of Stay in Patients With Surgical Aortic Valve Replacement and Transcutaneous Aortic Valve Implantation	11
Serial Assessment of Myocardial Injury Markers in Mechanically Ventilated Patients With SARS-CoV-2 (from the Prospective MaastrICCht Cohort)	11
Outcomes of Transcatheter Aortic Valve Implantation in Nonagenarians and Octogenarians (Analysis from the National Inpatient Sample Database)	11
Predictors and Mechanisms of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy	11
Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial)	11
Ventricular Septal Myectomy Decreases Long-Term Risk for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy	11
Comparison of Patients With Nonobstructive Coronary Artery Disease With Versus Without Myocardial Infarction (from the VA Clinical Assessment Reporting and Tracking [CART] Program)	11
Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study)	11
Usefulness of High Sensitivity Troponin T to Predict Long-Term Left Ventricular Dysfunction After ST-Elevation Myocardial Infarction	11
Frequency of Atrial Arrhythmia in Hospitalized Patients With COVID-19	11
Comparison in Patients < 75 Years of Age - Versus – Those > 75 Years on One-year-Events With Atrial Fibrillation and Left Atrial Appendage Occluder (From the Prospective Multicenter German LAARG	11
Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease	11
Impact of Mild Paravalvular Regurgitation on Long-Term Clinical Outcomes After Transcatheter Aortic Valve Implantation	11
Statin Treatment of COVID-19	10
Effect of Progression of Valvular Calcification on Left Ventricular Structure and Frequency of Incident Heart Failure (from the Multiethnic Study of Atherosclerosis)	10
Timing and Causes of Death in Acute Myocardial Infarction Complicated by Cardiogenic Shock (from the RETROSHOCK Cohort)	10
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CRE	10
Meta-Analysis of Transcatheter Aortic Valve Implantation in Patients With Stenotic Bicuspid Versus Tricuspid Aortic Valve	10
Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3)	10
Feasibility, Methodology, and Interpretation of Broad-Scale Assessment of Cardiorespiratory Fitness in a Large Community-Based Sample	10
Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis Hospitalized With Acute Heart Failure	10
Comparison of Outcomes of Coronary Artery Disease Treated by Percutaneous Coronary Intervention in 3 Different Age Groups (<45, 46-65, and >65 Years)	10
Usefulness of High-Sensitivity Cardiac Troponin T to Predict Long-Term Outcome in Patients with Hypertrophic Cardiomyopathy	10
Outcomes of Transcatheter Aortic Valve Replacement With Percutaneous Coronary Intervention versus Surgical Aortic Valve Replacement With Coronary Artery Bypass Grafting	10
Secular Trends in Cardiovascular Health in US Adults (from NHANES 2007 to 2018)	10
Usefulness of Semisupervised Machine-Learning-Based Phenogrouping to Improve Risk Assessment for Patients Undergoing Transcatheter Aortic Valve Implantation	10
Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination: Is Kounis Syndrome the Culprit?	10
Severe Obesity and Heart Failure	10
Prevalence of Aortic Valve Stenosis in Patients With ST-Segment Elevation Myocardial Infarction and Effect on Long-Term Outcome	10
Myocardial Geometry and Dysfunction in Morbidly Obese Adolescents (BMI 35–40 kg/m2)	10
State-Level Social Vulnerability Index and Healthcare Access in Patients With Atherosclerotic Cardiovascular Disease (from the BRFSS Survey)	10
Effect of Atorvastatin (10 mg) and Ezetimibe (10 mg) Combination Compared to Atorvastatin (40 mg) Alone on Coronary Atherosclerosis	10
Incidence and Predictors of Bleeding in Patients With Cancer and Atrial Fibrillation	10
Are We What We Eat? The Moral Imperative of the Medical Profession to Promote Plant-Based Nutrition	10
Independent Association of Fatty Liver Index With Left Ventricular Diastolic Dysfunction in Subjects Without Medication	10
Comparison of Frequency of Atrial Fibrillation in Blacks Versus Whites and the Utilization of Race in a Novel Risk Score	10
Impact of Postprocedural High-Sensitivity C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk with ST-Segment Elevation Myocardial Infarction With Percutaneous Coronary Intervention	10
Effect of Lipoprotein (a) Levels on Long-term Cardiovascular Outcomes in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries	10